HEADLINES

Patients with stage IV bladder cancer often have few treatment options and face low survival rates, but some much-needed hope may soon be on the way, thanks to a new discovery by University of Florida researchers.

The ocean is a vast, largely untapped resource holding secrets that could provide opportunities to develop new drug therapies that impact human health. Hendrik Luesch, Ph.D., professor and chair of the UF Department of Medicinal Chemistry in the College of Pharmacy, is committed to exploring and unlocking the medicinal potential of the ocean.

Thomas George, M.D., FACP., speaks about the ASCO GI 2022 Abstract – Phase II study of durvalumab following neoadjuvant chemoRT in operable rectal cancer: NSABP FR-2.

Lakeshia Cousin, Ph.D., APRN, AGPCNP-BC, joins Stephanie Jardine, BSN, R.N., oncology clinical specialist at ONS, to discuss cardio-oncology survivorship, the influence of social determinants of health, and how nurses can promote equity in care to improve outcomes for their patients. 

The University of Florida Health Cancer Center, and the Community Outreach and Engagement (COE) Steering Committee had a successful Cervical Cancer Town Hall that reached 5,579 people. The event discussed the importance of cervical cancer screenings and shared COE member survivor stories.

A main component of a groundbreaking cancer treatment system was delivered this weekend to UF Health’s Department of Radiation Oncology.

In December, surgeons at UF Health performed their first cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) to treat abdominal cancer in an adult patient. The surgery was successful, and the patient has been discharged and seen in clinic during the postoperative follow up.